Xinyuan Li

642 citations
36 papers · 472 indexed · h-index 12
Topics
Trigeminal Neuralgia and Treatments (10 papers)Botulinum Toxin and Related Neurological Disorders (7 papers)Facial Nerve Paralysis Treatment and Research (7 papers)

In The Last Decade

Xinyuan Li

34 papers receiving 467 citations

Peers

Xinyuan Li
Comparison fields: 5 of 81
  • Neurology 251
  • Pathology and Forensic Medicine 248
  • Molecular Biology 95
  • Oncology 43
  • Immunology 42
Replace Yoshimitsu Doi with:
Yoshimitsu Doi Japan
Barbara Teter United States
Chun‐Che Chu Taiwan
Ema Kantorová Slovakia
Wolfgang Feneberg Germany
Katherine G. Holste United States
Kesav Raghavan United States
Maria Dardioti Greece
George Katsamakis United States
Sami Abu Hamdeh Sweden
Xinyuan Li relative to Yoshimitsu Doi Japan Yoshimitsu Doi's profile →
Citations per field
00.5×5.7×
Yoshimitsu Doi · 1×
Citations per year

Countries citing papers authored by Xinyuan Li

Since Specialization
Citations

This map shows the geographic impact of Xinyuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinyuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinyuan Li more than expected).

Fields of papers citing papers by Xinyuan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinyuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinyuan Li. The network helps show where Xinyuan Li may publish in the future.

Co-authorship network of co-authors of Xinyuan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xinyuan Li. A scholar is included among the top collaborators of Xinyuan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinyuan Li. Xinyuan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 2
3 1
4 4
5 0
6 12
7 14
8 9
9 10
10 38
11 19
12 4
13 14
14 3
15 3
16 18
17 63
18 67
19 1
20 1

About Xinyuan Li

Xinyuan Li is a scholar working on Neurology, Pathology and Forensic Medicine and Neurology, having authored 36 papers that have together received 472 indexed citations. Recurring topics across this work include Trigeminal Neuralgia and Treatments (10 papers), Botulinum Toxin and Related Neurological Disorders (7 papers) and Facial Nerve Paralysis Treatment and Research (7 papers). The work is most often cited by research in Neurology (251 citations), Pathology and Forensic Medicine (248 citations) and Neurology (26 citations). Xinyuan Li has collaborated with scholars based in China, United States and British Virgin Islands. Frequent co-authors include Shiting Li, Xuhui Wang, Jun Zhong, Jin Zhu, Changyi Zhao, Ruizhe Zheng, Tingting Ying, Xiaohua Dong, Tongqi Li and Zhijie Zhao. Their work appears in journals such as Journal of Agricultural and Food Chemistry, Phytochemistry and Psychiatry Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026